Sign Up to like & get
recommendations!
0
Published in 2022 at "Future oncology"
DOI: 10.2217/fon-2021-1579
Abstract: This is an open-label, single-center, multi-cohort phase Ib trial, which consists of three cohorts, including cohort 1 (HER2 negative gastric or gastric esophageal junction adenocarcinoma), cohort 2 (esophageal squamous cell carcinoma and head and neck squamous…
read more here.
Keywords:
metronomic capecitabine;
capecitabine patients;
trial;
camrelizumab metronomic ... See more keywords